TWiV Special: Conversation with a COVID-19 patient, Ian Lipkin

Ian Lipkin joins Vincent to talk about his experience as a COVID-19 patient, and issues surrounding the disease and SARS-CoV-2 including limiting transmission, antivirals, vaccines, and much more. Hosts: Vincent Racaniello Guest: W. Ian Lipkin Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Center for Infection and Immunity Control the Contagion videos Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees. Send your virology questions and comments to twiv@microbe.tv
Source: This Week in Virology - MP3 Edition - Category: Virology Authors: Source Type: podcasts

Related Links:

Abstract COronaVIrus Disease 2019 (COVID-19) is an on-going pandemic attributed to a novel virus named SARS-CoV-2. Comparing the statistics of incidence and death rates between nations reveals that there is discrepancy amongst countries in these regards, even between countries that share borders. We herein present information from the literature indicating how cross-protection against COVID-19 conferred by the encephalitis vaccine could be the reason for lower fatality rate in the countries where immunization against encephalitis is widespread or included in national programs. This may pave the way for arriving at...
Source: Accident and Emergency Nursing - Category: Emergency Medicine Authors: Tags: Arch Acad Emerg Med Source Type: research
The Royal Society president says scientists must not be made scapegoats for policy failuresCoronavirus – latest updatesSee all our coronavirus coverageIn 1981, a virus that had jumped the species barrier some decades earlier to infect humans began to wreak havoc among the gay community in San Francisco and New York. A taskforce was set up to study the cause of this disease, and it took a few years to identify HIV as the definitive cause of Aids and its genome to be sequenced, and nearly 15 years before a cocktail of drugs meant that having an HIV infection was no longer a certain death sentence.Forty years later, the...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research Health policy Vaccines and immunisation Politics Science Infectious diseases Aids and HIV Source Type: news
AbstractThe ongoing global pandemic brought on by the spread of the novel coronavirus SARS-CoV-2 is having profound effects on human health and well-being. With no viable vaccine presently available and the virus being rapidly transmitted, governments and national health authorities have acted swiftly, recommending ‘lockdown’ policies and/or various levels of social restriction/isolation to attenuate the rate of infection. An immediate consequence of these strategies is reduced exposure to daylight, which can result in marked changes in patterns of daily living such as the timing of meals, and sleep. These disr...
Source: Sports Medicine - Category: Sports Medicine Source Type: research
Authors: Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, Abbott W, Mears E, Steele R, McKee J, Muscroft-Taylor A, Ameratunga S, Medlicott N, Das S, Rolleston W, Quiñones-Mateu M, Petousis-Harris H, Jordan A Abstract COVID-19 is a new zoonotic disease caused by the SARS-CoV-2 virus. Since its emergence in Wuhan City, China, the virus has rapidly spread across the globe causing calamitous health, economic and societal consequences. It causes disproportionately severe disease in the elderly and those with co-morbidities, such as hypertension and diabetes. There is currently no proven treatment ...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
NIH COVID-19 SIG Lecture Series SARS-CoV-2 is a newly emerged coronavirus responsible for the current COVID-19 pandemic. Coronavirus spike (S) glycoprotein trimers promote the virus ’ s entry into cells and are the main targets of the humoral immune response. We demonstrated that Angiotensin-converting enzyme 2 (ACE2) is a functional entry receptor for this novel coronavirus and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to ACE2, which correlates with the efficient spread of SARS-CoV-2 among humans. We used cryo-electron microscopy to determine the structures of the ...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
01:38 Trump vs the WHOPresident Trump has given the WHO an ultimatum in a tweet, threatening to pull out of the organisation within 30 days unless unclear demands are met. We discuss what this means for the pandemic, the USA and the future of international health cooperation.12:06 Where are we with vaccines?The first results from vaccine trials are in and they are encouraging, but scientists are still urging caution. We hear the lowdown on the types of vaccines being developed and what hope there is of rolling them out any time soon. News: Coronavirus vaccine trials have delivered their first results — but ...
Source: Nature Podcast - Category: Science Authors: Source Type: podcasts
A successful vaccine for prevention of SARS-CoV-2 infection may need to incorporate T-cell epitopes to induce a long-term memory T-cell immune response to the virus, according to one expert.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news
Politicians have become more cautious about immunisation prospects. They are right to beCoronavirus – latest updatesSee all our coronavirus coverageIt would be hard to overstate the importance of developing a vaccine to Sars-CoV-2 – it’s seen as the fast track to a return to normal life. That’s why the health secretary, Matt Hancock, said the UK was “throwing everything at it”.But while trials have been launched and manufacturing deals already signed – Oxford University is now recruiting 10,000 volunteers for the next phase of its research – ministers and their advisers have ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Science Health Infectious diseases Society Microbiology Immunology Medical research UK news Source Type: news
(American Association for the Advancement of Science) Bypassing clinical trials for a potential SARS-CoV-2 vaccine would be " catastrophic, " says Science Advances deputy editor Douglas Green in this Editorial. Instead, it's vital to take time to ensure any vaccine candidate's safety and investigate potential adverse
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Stanislaw P Stawicki, Rebecca Jeanmonod, Andrew C Miller, Lorenzo Paladino, David F Gaieski, Anna Q Yaffee, Annelies De Wulf, Joydeep Grover, Thomas J Papadimos, Christina Bloem, Sagar C Galw.ar, Vivek Chauhan, Michael S Firstenberg, Salvatore Di Somma, Donald Jeanmonod, Sona M Garg, Veronica Tucci, Harry L Anderson, Lateef Fatimah, Tamara J Worlton, Siddharth P Dubhashi, Krystal S Glaze, Sagar Sinha, Ijeoma Nnodim Opara, Vikas Yellapu, Dhanashree Kelkar, Ayman El-Menyar, Vimal Krishnan, S Venkataramanaiah, Yan Leyfman, Hassan Ali Saoud Al Thani, Prabath W B Nanayakkara, Sudip Nanda, Eric Cioè-Peña, Indrani Sarde...
Source: Journal of Global Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
More News: COVID-19 | Podcasts | SARS | Vaccines | Virology